Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial, Journal of Clinical Oncology, vol.31, issue.32, 2013. ,
DOI : 10.1200/JCO.2013.49.6968
Cilengitide: an RGD pentapeptide ??????3 and ??????5 integrin inhibitor in development for glioblastoma and other malignancies, Future Oncology, vol.7, issue.3, pp.339-354, 2011. ,
DOI : 10.2217/fon.11.8
Gene Silencing and Benefit from Temozolomide in Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.997-1003, 2005. ,
DOI : 10.1056/NEJMoa043331
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial, The Lancet Oncology, vol.13, issue.7, pp.707-715, 2012. ,
DOI : 10.1016/S1470-2045(12)70164-X
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?, Nature Reviews Neurology, vol.113, issue.1, pp.39-51, 2010. ,
DOI : 10.1038/nrneurol.2009.197
A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts, Acta Neuropathologica, vol.137, issue.5, pp.651-661, 2011. ,
DOI : 10.1007/s00401-011-0803-5
Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM, PLoS ONE, vol.121, issue.1, p.16146, 2011. ,
DOI : 10.1371/journal.pone.0016146.s005
Inactivation of the DNA repair gene O6-methylguanine- DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia, Cancer Res, vol.59, pp.793-797, 1999. ,
Validation of Real-Time Methylation-Specific PCR to Determine O6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation in Glioma, The Journal of Molecular Diagnostics, vol.10, issue.4, pp.332-337, 2008. ,
DOI : 10.2353/jmoldx.2008.070169
Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, methylight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 g, Cancer, vol.12, issue.17, pp.4201-4211, 2012. ,
DOI : 10.1002/cncr.27392
MGMT CpG island is invariably methylated in adult astrocytic and oligodendroglial tumors with IDH1 or IDH2 mutations, International Journal of Cancer, vol.113, issue.5, pp.1104-1113, 2012. ,
DOI : 10.1002/ijc.26499
Survival Model Predictive Accuracy and ROC Curves, Biometrics, vol.9, issue.1, pp.92-105, 2005. ,
DOI : 10.1093/biostatistics/kxh013
MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS, Statistics in Medicine, vol.15, issue.4, pp.361-387, 1996. ,
DOI : 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods, Journal of Neuro-Oncology, vol.16, issue.3, pp.311-322 ,
DOI : 10.1007/s11060-009-0031-1
URL : https://hal.archives-ouvertes.fr/inserm-00435222
Predictive impact of MGMT promoter methylation in glioblastoma of the elderly, International Journal of Cancer, vol.28, issue.6, pp.1342-1350, 2012. ,
DOI : 10.1002/ijc.27385
Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma, PLoS ONE, vol.63, issue.3, p.33449, 2012. ,
DOI : 10.1371/journal.pone.0033449.t003
MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR, Journal of Translational Medicine, vol.10, issue.1, 2012. ,
DOI : 10.1007/s11060-008-9600-y
Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy, British Journal of Cancer, vol.33, issue.1, pp.124-131, 2009. ,
DOI : 10.1097/nen.0b013e31815f65fb
Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients, Clinical Cancer Research, vol.15, issue.21, pp.6683-6693, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-2801
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network, Journal of Clinical Oncology, vol.27, issue.34, pp.5743-5750, 2009. ,
DOI : 10.1200/JCO.2009.23.0805
Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide, Journal of Neuro-Oncology, vol.16, issue.18, pp.311-316, 2011. ,
DOI : 10.1007/s11060-010-0324-4
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status, Acta Neuropathologica, vol.6, issue.4, pp.547-560, 2012. ,
DOI : 10.1007/s00401-012-1016-2